# Fluoxetine for Visual Recovery After Ischemic Stroke

> **NCT02737930** · PHASE2 · TERMINATED · sponsor: **Bogachan Sahin** · enrollment: 17 (actual)

## Conditions studied

- Acute Stroke
- Visual Field Loss

## Interventions

- **DRUG:** Fluoxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02737930
- **Lead sponsor:** Bogachan Sahin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05
- **Primary completion:** 2020-08
- **Final completion:** 2020-08
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Slow recruitment and lack of funding to expand to other sites.
- **Last updated:** 2021-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02737930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02737930, "Fluoxetine for Visual Recovery After Ischemic Stroke". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02737930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*